The Epigenetics of Migraine

Area of Science:

• Neurology
• Genetics
• Molecular Biology

Background:

• Migraine is a complex neurological disorder with unsatisfactory treatment outcomes.
• Current therapies target symptoms but don't fully address underlying pathophysiology.
• Genetics explains only a minor part of migraine susceptibility, highlighting the need for other regulatory mechanisms.

Purpose of the Study:

• To review current epigenetic findings related to migraine pathogenesis.
• To identify potential epigenetic therapeutic targets for migraine.
• To explore the role of DNA methylation, histone acetylation, and microRNAs in migraine.

Main Methods:

• Literature review of epigenetic studies in migraine.
• Focus on DNA methylation, histone acetylation, and microRNA-dependent regulation.
• Analysis of specific genes (e.g., CALCA, RAMP1) and microRNAs (e.g., miR-34a-5p) implicated in migraine.

Main Results:

• Several genes and microRNAs are associated with migraine symptoms, onset, chronification, and treatment response.
• Specific methylation patterns in genes like CALCA and SH2D5 are linked to migraine features.
• MicroRNAs such as miR-34a-5p and miR-382-5p show potential in predicting treatment response.

Conclusions:

• Epigenetic modifications are crucial in understanding migraine pathophysiology.
• Epigenetic targets offer promising avenues for novel migraine therapies and monitoring.
• Larger studies are required to validate these findings and establish clinical utility.